Ambulatory Flashcards
(307 cards)
Medication tx for BPH
1st line = alpha blockers (-sin)
2nd line = 5-alpha reductase inhibitor (prevents T –> DHT; DHT causes hyperplasia) ex. finasteride
Combo if prostate large
Symptoms of BPH
Weak stream Intermittency Straining Emptying incomplete Hesitency Post-void dribbling Nocturia
Indications for BPH surgery
Urinary retention Recurrent UTI Recurrent or persistent gross hematuria Bladder stones Renal insufficiency
Mammogram screening regular risk women
Q2-3y 50-74
No routine clinical breast exam alone or in conjunction with mammography to screen for breast CA
No need to recommend routine breast self-exam
Mammogram screening for high risk women
Q1 yr 40-74
Colorectal CA screening for average risk individual
Begin at age 50
FOBT q1-2yr
Colonoscopy/flex sig q10y
No screening after age 75
Colorectal CA screening for individual with +ve fam hx for HNPCC or FAP
- Genetic counselling and special screening
- HNPCC: colonoscopy q1-2y starting age 20 or 10y younger than earliest case in family (whichever first)
FAP: Sigmoidoscopy annually, starting age 10-12
AAPC: Colonoscopy annually starting age 16-18
Colorectal CA screening for individual with 1st degree relative with CA or adenomatous polyp at age <60 or 2 or more 1st degree relatives with polyp or colon CA at any age
Colonoscopy q5y
Begin age 40 or 10y younger than earliest polyp or cancer case in family
Colorectal CA screening for individual with one 1st degree relative with cancer or adomatous polyp affected at age >60 or 2 or more second degree relatives with polyps or colon CA
Average risk screening
Begin at age 40
Colorectal CA screening for individual with one second degree relative or third degree relative affected
Average risk screening
Begin at age 50
Cervical CA screening
Pap smear age >/= 25 q3y
Once age >/= 70, if 3 normal tests in a row and no abnormal tests in last 10y, can discontinue screening
Cervical CA screening, inadequate sample
Repeat cytology in 3mo
Abnormal squamous cell of unknown significance (ASCUS)
<30y.o. = repeat cytology in 6mo
> 30 = HPV DNA testing
If Positive –> colposcopy
Abnormal squamous cells cannot rule out high grade squamous intraepithelial lesion (ASC-H)
Colposcopy
Atypical glandular cells of unknown significance (AGUS)
Colposcopy +/- endometrial sampling
Low grade squamous intraepithelial lesion (LSIL)
Colposcopy OR repeat cytology in 6mo
Important points for cervical screening
- Pregnant women and women who have sex with women should follow routine cervical screening
- Hysterectomy = total –> only swab vaginal vault if hx of uterine malignancy/dysplasia
= subtotal –> continue regular screening
Routine prostate CA screening
PSA test NOT RECOMMENDED for any age group
Dyslipidemia screening
q1-3y in males >40y.o. and females >40y.o. or who are menopausal
OR at any age with additional dyslipidemia risk factors
Framingham Risk Score
10yr mortality risk
<10% = low risk
10-19% = Moderate risk
>20% = High risk
Target for dyslipidemia tx
=2mmol/L LDL-C or >/= 50% decrease
When to tx dyslipidemia
High risk –> tx all
Moderate risk –> tx if LDL >/= 3.5mmol/L, ApoB >1.2g/L or Non-HDL-C >4.3; or men >/=50 or women >/= 60 with one additional RF (ie. low HDL, impaired fasting glucose, high waist circumference, smoker, HTN)
Low risk –> tx if LDL >/= 5 or familial hypercholesterolemia
Monitor lipids q6-12mo if adequate response on statin
Statin MOA
HMG-CoA reductase inhibitors
Other dyslipidemia tx option
Ezetimibe (cholesterol absorption inhibitor) - post-ACS, combine with statin for reduced mortality benefit